PharmaCyte Biotech, Inc. (PMCB)

Company Overview
Nuvilex is an innovative company which aims at ionitiating a paradigm shift, generating revenue at the same time as creating cancer and other cell related solutions to treat important human diseases, such as pancreatic cancer while retaining our connections to natural products. The present effort underway will give rise to dramatic advances in cancer therapy and benefit millions of people worldwid
read more

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Jul 06, 2015

Hotstocked Precision will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 05:08AM EDT July 06, 2015
$ 0.108   0 (0%)
Today's Open: 0.108 Previous Close: 0.108
Today's High: 0.108 Volume: 0
Today's Low: 0.108 Avg Vol: 2,177,033
52 Week High: 0.3348 Bid (size): 0
52 Week Low: 0.095 Ask (size): 0

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: Meadows Corporate Park I, 12510 Prosperity Boulevard, Silver Spring, MD 20904, United States
Mailing Address: -
Phone: 240-696-6859
Fax: -
Website: http//www.nuvilex.com

Company Details:

Symbol: PMCB
SIC: -
State location: MD
Sector: -
State of Inc: NV
Employees: 1
Type: -

Key executives:

Name Age Position
2015
Dr. Gerald W. Crabtree 2015 COO
Patricia Gruden 2015 Chairman of the Board of Directors and CFO
Robert F. Ryan 2015 President, CEO

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Jul 06, 2015

This free program will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Pops on New PR June 30, 2015

On Friday Pharmacyte Biotech Inc (OTCMKTS:PMCB) was back to lows of just over $0.10 per share. A press release that the company dropped near the opening bell yesterday reversed its red streak and pushed PMCB to a close 22% in the green. read more

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Struggles Under Ongoing Pumping June 25, 2015

Pharmacyte Biotech Inc (OTCMKTS:PMCB) has not been doing particularly well over the last couple of months. An excited spasm sent the ticker over $0.20 per share but that lasted a couple of sessions. Ever since PMCB has been steadily trudging downhill, w... read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Crashes Horribly June 1, 2015

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) crashed 9.26% on Friday, in spite of having a newly-issued and positive piece of PR. read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB)'s Recovery Didn't Last May 8, 2015

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) had a nice little bounce on Wednesday, but yesterday's trading session nearly wiped all of its gains, in spite of the investors' relative inactivity. read more

LATEST STOCK PROMOTIONS

OTCJ : PharmaCyte's (PMCB) National TV Debut Jul 01, 2015, 12:39

   July 1, 2015 Volume XVIII, Issue 32   OTC Journal Newsletter   PharmaCyte's (PMCB) National TV Debut I could not find yesterday's broadcast of Newswatch featuring PMCB's technology that was slated for the Discovery Channel at 7AM. I have about 7 versions of the Discovery Channel on my cable system (AT&T Uverse), and it wasn't on any of them. However, broadcast schedules read more

Promoter: OTCJournal Paying Party: UNKNOWN Max Profit: 0.66% Gain at close: Pending
Stock: pmcb Compensation: $14,000 Avg $ Volume for Period: UNKNOWN

#Cannabis Accumulated (Update) #Oversold / WATCH IT! Jul 01, 2015, 12:17

    ★ Update (10Day 30M Candles) PharmaCyte Biotech | PMCB ★ Welcome To PharmaCyte Biotech, Inc. (OTQCB) PMCB PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live read more

Promoter: JetLife Paying Party: UNKNOWN Max Profit: 2.07% Gain at close: Pending
Stock: pmcb Compensation: $3,000 Avg $ Volume for Period: UNKNOWN

And The Pullback: #Cannabis Accumulated BREAKOUT! Details.. Jun 30, 2015, 18:21

    ★ Next Flight: PharmaCyte Biotech, Inc. (OTCQB) PMCB ★ Welcome To PharmaCyte Biotech, Inc. (OTQCB) PMCB PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live read more

Promoter: JetLife Paying Party: UNKNOWN Max Profit: 2.07% Gain at close: Pending
Stock: pmcb Compensation: $3,000 Avg $ Volume for Period: UNKNOWN

Nuvilex, Inc. (NVLX) MESSAGE BOARD

Post # Subject Re Name Date
1 Such a deep anewsr! GD&RVVF 0
2 I love these areltics. How many words can... 0
3 Well, I think the Fed has to do a lot... 0
4 I just love how optimistic Jim Cramer and... 0
5 Dear Minamar,Can you give me some more... 0
6 Well mamiadcaa nuts, how about that. 0
7 I hope so 0
8 I'm a Dollarniare now! The scams on otc... 0
9 yes we are ging to be millionaires but it... 1
10 chemo kills weed does not 0
11 What happened to this stock today? It's... 0
12 Oh what happened? 2
13 Tanking like a ROCK!! Alpha Articles out!!! 4
14 FDA possible approval response to NVLX... 1
15 Yes it can 0
16 Man! I'd personally write some options... 0
17 20 Ducats? You jest my dear buffoon! 0
18 Oh Sheeheeheeheet! NVLX is fo' real ?... 0
19 50:1 split? Ha ha 0
20 with a 50:1 Reverse stock split! Yes... 0